PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
ASK1 762 Target Target Glutathione Peroxidase 6 13 1 0.01 -0.96 0.08 0.70
AXL 633 Target Target CYR61 539 4 0.01 -0.99 0.01 0.71
ANGPTL4 289 Target Target APOC1 126 1 0.01 -0.99 0.01 0.71
ApoE2 517 Target Target APOA1 958 6 0.01 -0.99 0.01 0.71
CXCL3 145 Target Target CCL21 808 3 0.01 -0.99 0.02 0.71
CCNB1 160 Target Target CCL18 256 1 0.00 -0.99 0.01 0.71
ANGPTL4 289 Target Target Acetyl-Coa Carboxylase 1 118 1 0.01 -0.99 0.01 0.71
CCL7 274 Target Target Proteinase-Activated Receptor 1 133 1 0.01 -0.99 0.01 0.71
Thromboembolic Disease 3,336 Disease Target D-Dimer 6,185 86 0.02 -0.98 0.03 0.71
Metabotropic Glutamate Receptor 2 72 Target Target Glutamate Receptor 1 352 1 0.01 -0.99 0.01 0.71
Platelet Aggregation 25,460 Disease Target Eptifibatide 772 194 0.04 -0.86 0.25 0.71
CD1A 2,739 Target Target CD34 24,598 317 0.04 -0.93 0.12 0.71
BMX 185 Target Target BRK 236 1 0.00 -1.00 0.01 0.71
Bone Cancer 798 Disease Target EPHB1 137 3 0.01 -0.99 0.02 0.71
CD95 4,266 Target Target Apo I 55 11 0.02 -0.89 0.20 0.71
CD95 4,266 Target Target Sphingomyelinase 3,060 58 0.02 -0.98 0.02 0.71
ANGPT1 81 Target Target EPHB4 329 1 0.01 -0.99 0.01 0.71
Eotaxin-3/CCL26 26 Target Target CXCL11 526 1 0.01 -0.98 0.04 0.71
BMP-2 3,889 Target Target Activin A 2,048 45 0.02 -0.98 0.02 0.71
EGF 27,487 Target Target ERBB3 1,154 251 0.04 -0.88 0.22 0.71
CD254 9 Target Target CCL21 808 1 0.01 -0.94 0.11 0.71
Thromboembolic Disease 3,336 Disease Target Antithrombin 13,773 196 0.03 -0.96 0.06 0.71
Androgen Receptor 12,918 Target Target Glucocorticoid Receptor 10,306 293 0.03 -0.97 0.03 0.71
BMP-6 386 Target Target Activin A 2,048 12 0.01 -0.98 0.03 0.71
CD146 729 Target Target CD34 24,598 190 0.04 -0.86 0.26 0.71
CCL19 658 Target Target CCL8 197 3 0.01 -0.99 0.02 0.71
BMP-7 1,112 Target Target Activin A 2,048 19 0.01 -0.99 0.02 0.71
COP-1 118 Target Target CYR61 539 2 0.01 -0.99 0.02 0.71
Acetyl-Coa Carboxylase 1 118 Target Target ADRP 537 2 0.01 -0.99 0.02 0.71
CCL21 808 Target Target Exodus-3 8 1 0.01 -0.93 0.12 0.71
CAMK2D 21 Target Target CYR61 539 1 0.01 -0.97 0.05 0.71
ANGPT2 105 Target Target BMPR1A 279 1 0.01 -0.99 0.01 0.71
DC-CK1 22 Target Target CXCL11 526 1 0.01 -0.98 0.05 0.71
AFP 9,751 Target Target Chorionic Gonadotropin beta 936 86 0.03 -0.95 0.09 0.71
CCL7 274 Target Target ANGPT2 105 1 0.01 -0.99 0.01 0.71
Steroid 5-Alpha-Reductase 293 Target Target 11-Beta-Hydroxylase 721 4 0.01 -0.99 0.01 0.71
BMP-2B 18 Target Target BMP-7 1,112 2 0.01 -0.94 0.11 0.71
CRG-2 41 Target Target CXCL10 2,386 6 0.02 -0.92 0.15 0.71
CD22 1,591 Target Target Ricin 3,034 34 0.02 -0.98 0.02 0.71
CCL18 256 Target Target CXCL2 750 4 0.01 -0.99 0.02 0.71
APOA1 958 Target Target APOE 12,771 118 0.03 -0.93 0.12 0.71
CCL18 256 Target Target CXCL10/IP-10 114 1 0.01 -0.99 0.01 0.71
CD22 1,591 Target Target BLyS 457 11 0.01 -0.98 0.02 0.71
FABP1 90 Target Target BMPR1A 279 1 0.01 -0.99 0.01 0.71
CCL4 5,638 Target Target CCL8 197 28 0.03 -0.92 0.14 0.71
CCL7 274 Target Target CCL4 5,638 32 0.03 -0.94 0.12 0.71
Aldactone (Spironolactone)- FDA 18 Drug Target Aldosterone Receptor 528 1 0.01 -0.97 0.06 0.71
Angiostatin K1-3 17 Target Target ETS1 539 1 0.01 -0.97 0.06 0.71
CCNB1 160 Target Target Alpha-Internexin 217 1 0.01 -0.99 0.01 0.71
High Affinity Nerve Growth Factor Receptor 47 Target Target ELC 355 1 0.01 -0.99 0.02 0.71